Erythrocyte glutathione levels as long-term predictor of transition to psychosis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Erythrocyte glutathione levels as long-term predictor of transition to psychosis
Authors
Keywords
-
Journal
Translational Psychiatry
Volume 7, Issue 3, Pages e1064
Publisher
Springer Nature
Online
2017-03-22
DOI
10.1038/tp.2017.30
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cortisol awakening response in patients with psychosis: Systematic review and meta-analysis
- (2016) Maximus Berger et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Genetic Polymorphism Associated Prefrontal Glutathione and Its Coupling With Brain Glutamate and Peripheral Redox Status in Early Psychosis
- (2016) Lijing Xin et al. SCHIZOPHRENIA BULLETIN
- Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers
- (2016) S R Clark et al. Translational Psychiatry
- Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosis
- (2015) Stefan Smesny et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Resting cortisol level, self-concept, and putative familial environment in adolescents at ultra high-risk for psychotic disorders
- (2015) Emily E. Carol et al. PSYCHONEUROENDOCRINOLOGY
- Much ado about much: Stress, dynamic biomarkers and HPA axis dysregulation along the trajectory to psychosis
- (2015) Jai L. Shah et al. SCHIZOPHRENIA RESEARCH
- Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study
- (2015) G. Paul Amminger et al. Nature Communications
- Morning cortisol levels in schizophrenia and bipolar disorder: A meta-analysis
- (2014) Leah Girshkin et al. PSYCHONEUROENDOCRINOLOGY
- N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
- (2013) Mehdi Farokhnia et al. CLINICAL NEUROPHARMACOLOGY
- A Mechanistic Approach to Preventing Schizophrenia in At-Risk Individuals
- (2013) Bita Moghaddam NEURON
- Long-term Follow-up of a Group at Ultra High Risk (“Prodromal”) for Psychosis
- (2013) Barnaby Nelson et al. JAMA Psychiatry
- Predicting Psychosis
- (2012) Paolo Fusar-Poli ARCHIVES OF GENERAL PSYCHIATRY
- HPA-axis function, symptoms, and medication exposure in youths at clinical high risk for psychosis
- (2012) G. Sugranyes et al. JOURNAL OF PSYCHIATRIC RESEARCH
- N-acetylcysteine as a potentially useful medication to prevent conversion to schizophrenia in at-risk individuals
- (2012) Elson Asevedo et al. REVIEWS IN THE NEUROSCIENCES
- Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal study
- (2012) David Fraguas et al. SCHIZOPHRENIA RESEARCH
- Reduced antioxidant defense in early onset first-episode psychosis: a case-control study
- (2011) Juan Antonio Micó et al. BMC Psychiatry
- Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients
- (2011) Monia Raffa et al. BMC Psychiatry
- Genetic Dysregulation of Glutathione Synthesis Predicts Alteration of Plasma Thiol Redox Status in Schizophrenia
- (2010) René Gysin et al. ANTIOXIDANTS & REDOX SIGNALING
- Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View
- (2010) Jeffrey K. Yao et al. ANTIOXIDANTS & REDOX SIGNALING
- Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders
- (2010) G. Paul Amminger et al. ARCHIVES OF GENERAL PSYCHIATRY
- Redox dysregulation, neurodevelopment, and schizophrenia
- (2009) Kim Q Do et al. CURRENT OPINION IN NEUROBIOLOGY
- Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients
- (2009) Monia Raffa et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
- (2008) Michael Berk et al. BIOLOGICAL PSYCHIATRY
- Ethyl-Eicosapentaenoic Acid in First-Episode Psychosis. A 1H-MRS Study
- (2008) Gregor E Berger et al. NEUROPSYCHOPHARMACOLOGY
- Validation of “prodromal” criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up
- (2008) Alison R. Yung et al. SCHIZOPHRENIA RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search